One share of BNTX stock can currently be purchased for approximately $117.56. The company can be reached via phone at 49-61-31908-40 or via email at [email protected]. BioNTech has only been the subject of 4 research reports in the past 90 days. Get BioNTech SE (BNTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Stay up to date with the BioNTech tokenized stock Bittrex (BNTX) price prediction on the basis of hitorical data. BioNTech SE - ADR market prognosis, BioNTech SE - ADR quote is equal to 117.490 USD at 2021-02-16. Eight equity analysts forecast the average price in 12 months at $42.88 with a high forecast of $53.00 and a low forecast of $38.00. Price Target BNTX forecast tomorrow, BioNTech tokenized stock FTX price equal to 117.220 USD at 2021-02-13. Earnings BioNTech (NASDAQ:BNTX) Earnings Information. Based on 6 analysts offering 12 month price targets for BioNTech SE in the last 3 months. BioNTech share price average forecast for Nov 2021 is: 141.611 The dynamics are positive. You can opt out at any time. Not within a year. Turning out attention to how the BioNTech SE stock has performed in comparison to its peers in the industry, here’s what we find: BNTX’s stock is +2% on the day and +216.12% in the past 12 months, while Amgen Inc (AMGN) traded +1.42% in the last session and was positioned +13.97% up on its price 12 months ago. BioNTech stock forecast for Jan 2022. one Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Learn everything you need to know about successful options trading with this three-part video course. And at $11 billion, it has only half of Moderna's market capitalization. The company earns $-200,540,000.00 in net income (profit) each year or ($0.95) on an earnings per share basis. © BioNTech last posted its quarterly earnings data on November 15th, 2020. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like BioNTech SE - ADR (BNTX). Some companies that are related to BioNTech include Gilead Sciences (GILD), Moderna (MRNA), Biogen (BIIB), Seagen (SGEN), Novozymes A/S (NVZMY), Novavax (NVAX), argenx (ARGX), Bio-Techne (TECH), QIAGEN (QGEN), Repligen (RGEN), CRISPR Therapeutics (CRSP), Neurocrine Biosciences (NBIX), Adaptive Biotechnologies (ADPT), Fate Therapeutics (FATE) and Vir Biotechnology (VIR). roxana — (NASDAQ: BNTX) BioNTech SE's current Earnings Per Share (EPS) is -$0.96. Your current $100 investment may be up to $418.63 in 2026. Will BNTX price drop? The official website for BioNTech is www.biontech.de. According to TipRanks’ latest BioNTech stock prediction, based on seven analysts offering a year-long price target, the average price target for BNTX is $111.17, which represents a 13.2 percent decline from the previous price of $128.11, and is 14.4 per cent down on its 52-week high of $129.90. On average, analysts forecast that BNTX's EPS will be $11.30 for 2021, with the lowest EPS forecast at $7.77, and the highest EPS forecast at $14.56. Term Box: MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Wall Street analysts have given BioNTech a "Hold" rating, but there may be better short-term opportunities in the market. Sign in, Not a member? When will BioNTech SE - ADR price drop? Based on our forecasts, a long-term increase is expected, the "BNTX" stock price prognosis for 2026-01-23 is 471.430 USD. BioNTech tokenized stock Bittrex price prediction in 2021 - up to $175.51 (BNTX/USD), BNTX price prediction, BioNTech tokenized stock Bittrex(BNTX) forecast. expected to be around +318.63%. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 10 day forcast looks amazing and totally contradicts the 1 year forecast. Historical Will BioNTech SE - ADR stock price fall? Best BioNTech SE - ADR forecast, Learn more. The BNTX stock price can go up The BNTX ("BNTX" ) Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. According to 10 analysts, the average rating for BioNTech SE stock is "Buy." We'll be curious to see if these new … According to our analysis, this will not happen. The forcast looks uncalculated - is there an error on this page? Short-term and long-term BNTX (BioNTech SE - ADR) BioNTech has received 54.14% “outperform” votes from our community. Looking for new stock ideas? Fundamental company data provided by Zacks Investment Research. BNTX prediction, With a 5-year investment, the revenue is How will BioNTech SE - ADR stock price increase? BioNTech SE - ADR stock has gained 338.83% since Thursday, October 10, 2019 when BNTX began trading. BNTX stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Primecap Management Co. CA, Credit Suisse AG, Bamco Inc. NY, SG Americas Securities LLC, Redwood Investments LLC, Koshinski Asset Management Inc., and Koshinski Asset Management Inc.. Shares of BNTX can be purchased through any online brokerage account. The business had revenue of $67.50 million for the quarter, compared to the consensus estimate of $50.53 million. ), BioNTech has received 61 “underperform” votes. Please log in to your account or sign up in order to add this asset to your watchlist. View BioNTech's earnings history. , and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives BNTX stock a score of 32 out of a possible 100.. That rank is influenced by a long-term technical score of 0. Pessimistic forecast: 86.38 Optimistic: 98.99 BioNTech stock forecast for Feb 2022. future stock price will be If you buy BioNTech tokenized stock FTX for 100 dollars today, you will get a total of 0.853 BNTX. Vote “Outperform” if you believe BNTX will outperform the S&P 500 over the long term. Strategy, MD & Head of Global External Communications, Start Your Risk-Free Trial Subscription Here, Luxury car brand Jaguar to go all-electric by 2025, The Latest: Variants-wary Germany turns back 5,000 at border, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, The Latest: Britain orders quarantine for many travelers, Biden faces questions about commitment to minimum wage hike, Got no milk: Nestle creates vegan KitKat bar, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 3 Oil & Gas Stocks Worth Watching in 2021, U.S. Steel Stock is an Economic Recovery Buy Here, American Axle Manufacturing Stock is an Automotive Recovery and Electrification Play, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Serbia donates thousands of doses of Pfizer/BioNTech vaccine to North Macedonia - Reuters, BioNTech SE ADR underperforms Friday when compared to competitors - MarketWatch, FOCUS-BioNTech, Moderna shore up supplies of key COVID-19 vaccine ingredients - Yahoo Finance, Pfizer, BioNTech To Supply U.S. With 100M Additional Doses Of COVID-19 Vaccine - Benzinga, Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine - GlobeNewswire, FOCUS-BioNTech, Moderna shore up supplies of key COVID-19 vaccine ingredients, BioNTech Supercharges a Factory to Produce More Covid Vaccine, BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch, TriRadial Solutions Recognized for Contributions to BioNTech COVID-19 Vaccine - Yahoo Finance, BioNTech: Undervalued Based On COVID-19 Vaccine Revenue, But Moderna Is The Better Long-Term Bet - Seeking Alpha, One dose of Pfizer-BioNTech vaccine offers two-thirds protection from COVID-19 - Fortune, TriRadial Solutions Recognized for Contributions to BioNTech COVID-19 Vaccine - PRNewswire, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. 7 Wall Street analysts have issued 12-month target prices for BioNTech's shares. On average, they anticipate BioNTech's share price to reach $102.75 in the next year. From where I can buy COWI? BNTX: Get the latest BioNTech (ADRs stock price and detailed information including BNTX news, historical charts and realtime prices. According to analysts' consensus price target of $102.75, BioNTech has a forecasted downside of 12.6% from its current price of $117.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. BioNTech SE - ADR projections, To see all exchange delays and terms of use please see disclaimer. BioNTech boosts 2021 vaccine supply forecast to 2bn doses: company A new factory in Marburg, Germany, is also expected to open in February, … BNTX's rank also includes a short-term technical score … Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I/II clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. Stay up to date with the BioNTech tokenized stock Bittrex (BNTX) price prediction on the basis of hitorical data. MarketBeat's community ratings are surveys of what our community members think about BioNTech and other stocks. However, solely looking at the historical price movement is usually misleading. In the past three months, BioNTech insiders have not sold or bought any company stock.